Meridian Bioscience Inc. (VIVO) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
3471 RIVER HILLS DR CINCINNATI, OH 45244 |
| State of Incorp. | OH |
| Fiscal Year End | September 30 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 49,771 | 53,514 | 62,397 | 59,763 | 57,072 | 47,226 | |||
| Cash and cash equivalent | 49,771 | 53,514 | 62,397 | 59,763 | 57,072 | 47,226 | |||
| Receivables | 53,568 | 38,512 | 35,608 | 32,336 | 29,106 | 27,102 | |||
| Inventory, net of allowances, customer advances and progress billings | 76,842 | 61,264 | 39,617 | 41,993 | 41,493 | 45,057 | |||
| Inventory | 76,842 | 61,264 | 39,617 | 41,993 | 41,493 | 45,057 | |||
| Other undisclosed current assets | 12,626 | 8,900 | 7,139 | 4,961 | 6,204 | 7,406 | |||
| Total current assets: | 192,807 | 162,190 | 144,761 | 139,053 | 133,875 | 126,791 | |||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 43,214 | 31,120 | 30,567 | 29,995 | 30,510 | 30,450 | |||
| Intangible assets, net (including goodwill) | 81,630 | 91,837 | |||||||
| Goodwill | 54,926 | 61,982 | |||||||
| Intangible assets, net (excluding goodwill) | 26,704 | 29,855 | |||||||
| Derivative instruments and hedges | 815 | ||||||||
| Restricted cash and investments | 1,000 | 1,000 | |||||||
| Other noncurrent assets | 213,701 | 211,951 | 150,150 | 82,329 | 421 | 353 | |||
| Other undisclosed noncurrent assets | 1,526 | 1,392 | |||||||
| Total noncurrent assets: | 256,915 | 243,071 | 180,717 | 112,324 | 115,902 | 125,032 | |||
| TOTAL ASSETS: | 449,722 | 405,261 | 325,478 | 251,377 | 249,777 | 251,823 | |||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 39,429 | 37,516 | 20,914 | 18,923 | 16,292 | 18,821 | |||
| Taxes payable | 3,848 | 3,524 | 1,980 | 335 | 1,248 | 1,482 | |||
| Employee-related liabilities | 16,853 | 16,661 | 7,938 | 7,263 | 4,536 | 7,106 | |||
| Accounts payable | 11,701 | 11,969 | 7,238 | 6,260 | 7,719 | 7,627 | |||
| Accrued liabilities | 7,027 | 5,362 | 3,758 | 5,065 | 2,789 | 2,606 | |||
| Debt | 5,250 | 4,500 | 3,750 | ||||||
| Estimated litigation liability | |||||||||
| Business combination, contingent consideration, liability | 12,619 | 2,095 | |||||||
| Other undisclosed current liabilities | 7,728 | 2,389 | |||||||
| Total current liabilities: | 47,157 | 52,524 | 20,914 | 24,173 | 22,887 | 22,571 | |||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 63,932 | 73,502 | 75,824 | 44,930 | 50,147 | 54,610 | |||
| Long-term debt, excluding current maturities | 60,000 | 68,824 | 75,824 | 44,930 | 50,147 | 54,610 | |||
| Liabilities, other than long-term debt | 2,902 | 20,429 | 37,034 | 6,074 | 6,370 | 7,493 | |||
| Accounts payable and accrued liabilities | 469 | 549 | 549 | 441 | |||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | ✕ | 3,769 | 4,455 | 2,753 | ||
| Deferred income tax liabilities | 1,055 | 3,804 | 2,366 | ✕ | ✕ | ✕ | |||
| Liability, pension and other postretirement and postemployment benefits | 1,840 | 1,917 | 1,864 | 1,680 | 1,628 | ||||
| Other liabilities | 175 | 233 | |||||||
| Operating lease, liability | 3,932 | 4,678 | ✕ | ✕ | ✕ | ||||
| Business combination, contingent consideration, liability | 1,000 | 13,290 | 32,202 | 235 | 2,383 | ||||
| Derivative instruments and hedges, liabilities | 203 | 713 | 729 | ||||||
| Other undisclosed noncurrent liabilities | 7,429 | 11,177 | 739 | 782 | 788 | 677 | |||
| Total noncurrent liabilities: | 74,263 | 105,108 | 113,597 | 51,786 | 57,305 | 62,780 | |||
| Total liabilities: | 121,420 | 157,632 | 134,511 | 75,959 | 80,192 | 85,351 | |||
| Equity | |||||||||
| Equity, attributable to parent | 328,302 | 247,629 | 190,967 | 175,418 | 169,585 | 166,472 | |||
| Treasury stock, value | |||||||||
| Additional paid in capital | 147,403 | 140,195 | 132,834 | 129,193 | 125,608 | 122,356 | |||
| Accumulated other comprehensive income (loss) | 198 | (1,860) | (4,975) | (3,377) | (2,946) | (5,516) | |||
| Retained earnings | 180,701 | 109,294 | 63,108 | 49,602 | 46,923 | 49,632 | |||
| Total equity: | 328,302 | 247,629 | 190,967 | 175,418 | 169,585 | 166,472 | |||
| TOTAL LIABILITIES AND EQUITY: | 449,722 | 405,261 | 325,478 | 251,377 | 249,777 | 251,823 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 317,896 | 253,667 | 201,014 | 213,571 | 200,771 | 196,082 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | ✕ | 200,771 | 196,082 | |
| Cost of revenue (Cost of Product and Service Sold) | (116,748) | (97,419) | (82,689) | (83,110) | (75,938) | (68,295) | ||
| Gross profit: | 201,148 | 156,248 | 118,325 | 130,461 | 124,833 | 127,787 | ||
| Operating expenses | (108,114) | (94,924) | (85,626) | (98,877) | (87,451) | (76,409) | ||
| Operating income: | 93,034 | 61,324 | 32,699 | 31,584 | 37,382 | 51,378 | ||
| Nonoperating expense | (2,583) | (2,031) | (1,142) | (1,204) | (953) | (734) | ||
| Investment income, nonoperating | 142 | 681 | 418 | 171 | 67 | |||
| Other nonoperating income (expense) | (1,705) | 459 | 122 | (102) | 518 | 96 | ||
| Interest and debt expense | (1,878) | (2,632) | (1,945) | (1,520) | (1,642) | (897) | ||
| Income from continuing operations before equity method investments, income taxes: | 88,573 | 56,661 | 29,612 | 28,860 | 34,787 | 49,747 | ||
| Other undisclosed income from continuing operations before income taxes | 1,878 | 2,632 | 1,945 | 1,520 | 1,642 | 897 | ||
| Income from continuing operations before income taxes: | 90,451 | 59,293 | 31,557 | 30,380 | 36,429 | 50,644 | ||
| Income tax expense | (19,044) | (13,107) | (7,175) | (6,531) | (14,872) | (18,415) | ||
| Income from continuing operations: | 71,407 | 46,186 | 24,382 | 23,849 | 21,557 | 32,229 | ||
| Income before gain (loss) on sale of properties: | 71,407 | 46,186 | 24,382 | 23,849 | 21,557 | 32,229 | ||
| Net income available to common stockholders, diluted: | 71,407 | 46,186 | 24,382 | 23,849 | 21,557 | 32,229 | ||
Comprehensive Income ($ in thousands)
| 9/30/2022 | 9/30/2021 | 9/30/2020 | 9/30/2019 | 9/30/2018 | 9/30/2017 | 9/30/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net income: | 71,407 | 46,186 | 24,382 | 23,849 | 21,557 | 32,229 | ||
| Comprehensive income: | 71,407 | 46,186 | 24,382 | 23,849 | 21,557 | 32,229 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 2,058 | 3,115 | (1,598) | (431) | 2,570 | (3,186) | ||
| Comprehensive income, net of tax, attributable to parent: | 73,465 | 49,301 | 22,784 | 23,418 | 24,127 | 29,043 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.